BREAKING
Hims & Hers Health, Inc. (HIMS) Jumps 8.6% to $20.41 22 minutes ago BIO-key International, Inc. (BKYI) Q4 2025 Earnings Recap 25 minutes ago Arrowhead Pharmaceuticals, Inc. (ARWR) Jumps 7.3% to $61.87 32 minutes ago FactSet Research Systems Inc. (FDS) Q2 2026 Earnings Recap 33 minutes ago Reading International, Inc. (RDI) Reports Q4 Earnings 1 hour ago Sunrun Inc. (RUN) Jumps 7.6% to $13.06 2 hours ago IMUNON 2025 Financial Review 2 hours ago BIO-key International, Inc. (BKYI) Reports Q4 Earnings 2 hours ago SiTime Corporation (SITM) Jumps 8.9% to $339.00 2 hours ago Purple Innovation, Inc. (PRPL) Reports Q4 Earnings 3 hours ago Hims & Hers Health, Inc. (HIMS) Jumps 8.6% to $20.41 22 minutes ago BIO-key International, Inc. (BKYI) Q4 2025 Earnings Recap 25 minutes ago Arrowhead Pharmaceuticals, Inc. (ARWR) Jumps 7.3% to $61.87 32 minutes ago FactSet Research Systems Inc. (FDS) Q2 2026 Earnings Recap 33 minutes ago Reading International, Inc. (RDI) Reports Q4 Earnings 1 hour ago Sunrun Inc. (RUN) Jumps 7.6% to $13.06 2 hours ago IMUNON 2025 Financial Review 2 hours ago BIO-key International, Inc. (BKYI) Reports Q4 Earnings 2 hours ago SiTime Corporation (SITM) Jumps 8.9% to $339.00 2 hours ago Purple Innovation, Inc. (PRPL) Reports Q4 Earnings 3 hours ago
ADVERTISEMENT
Company News

Hormel (HRL) expects sales growth for Q1 2026 and reaffirms full-year outlook

February 18, 2026 2 min read

Shares of Hormel Foods Corporation (NYSE: HRL) were up 4% on Wednesday. The company released its preliminary results for the first quarter of 2026, and reaffirmed its outlook for the full year. It also announced the sale of its whole-bird turkey business as part of its portfolio shaping efforts.

Prelim Q1 results

Hormel expects net sales of approx. $3 billion for the first quarter of 2026, up 1% year-over-year. Organic sales is expected to grow 2%, marking the fifth consecutive quarter of year-over-year organic sales growth. Earnings per share is expected to be $0.33 on a reported basis, and $0.34 on an adjusted basis for Q1.

The branded foods provider reaffirmed its organic sales and adjusted EPS outlook for fiscal year 2026. Organic sales growth is expected to be 1-4% for the year while adjusted EPS is estimated to range between $1.43-1.51, representing a growth of 4-10% YoY. HRL also reaffirmed its long-term growth targets of 2-3% organic net sales growth and 5-7% operating profit growth.

Sale of turkey business

Hormel has also agreed to sell its whole-bird turkey business to Life-Science Innovations (LSI). As per the deal, Hormel will sell its whole-bird production facility and feed mill in Minnesota, and associated transportation assets to LSI. The broader range of JENNIE-O branded products and the JENNIE-O brand name remain unaffected by the transaction. The sale is expected to close by the end of the second quarter of 2026, and have a minimal impact on adjusted FY2026 results.

ADVERTISEMENT